Search results
'Discovery's' Most Unexpected Star Doesn't Understand Star Trek Canon At All
Inverse· 3 hours agoAlthough she helps maintain the warp engine and the spore drive on the eponymous starship in Star...
Are the Republicans Sneakily Trying to Cut Food Stamps?
The New Republic via Yahoo News· 60 minutes agoThe Thrifty Food Plan, or TFP, estimates the costs needed to maintain a healthy diet, taking into...
Florida woman's ammunition arrest in Turks and Caicos is 5th of US tourist in recent weeks
NBC Miami· 2 hours agoThree of the arrests have prompted pleas for mercy from the governors of Oklahoma, Pennsylvania and...
Charles Schwab retains buy rating, stock target steady on leadership overhaul By Investing.com
Investing.com· 2 hours agoOn Friday, Charles Schwab Corp. (NYSE:SCHW) maintained its Buy rating and a stock price target of...
What is queerbaiting and how can we combat the phenomenon?
Pride via Yahoo News· 5 hours agoAnyone who identifies as anything on the LGBTQ+ spectrum already knows how difficult it is to ...
How Walmart Is ‘Firing On All Cylinders’
Barrons.com· 3 hours ago“Walmart’s business is firing on all cylinders,” Raymond James analysts led by Bobby Griffin wrote. The team raised their price target to $70 from $63,...
Putin and Xi no longer have a partnership of equals
BBC via Yahoo News· 1 hour agoFew leaders are afforded that honour - US President Barack Obama being among them back in 2014, when ties between the two were at their best. President...
Mizuho raises Sarepta Therapeutics stock target on FDA hopes By Investing.com
Investing.com· 5 hours agoOn Friday, Mizuho Securities maintained a Buy rating on shares of Sarepta Therapeutics...
Arcosa shares target raised at DA Davidson on EBITDA outlook By Investing.com
Investing.com· 4 hours agoOn Friday, DA Davidson maintained a positive outlook on Arcosa (NYSE:ACA) shares, raising the price...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
AOL· 58 minutes ago"We are pleased to announce that the European Patent Office decided to maintain the validity of Moderna's EP949 patent, one of the key patents currently asserted against Pfizer ...